Novel composition and methods for the treatment of immune disorders

Details for Australian Patent Application No. 2004234349 (hide)

Owner Genentech, Inc.

Inventors Chiu, Henry; Fong, Sherman; Baldwin, Daryl; Williams, P. Mickey; Ouyang, Wenjun; Grimaldi, J. Christopher; Clark, Hilary; Fedorowicz, Grazyna

Agent Griffith Hack

Pub. Number AU-A-2004234349

PCT Pub. Number WO2004/096848

Priority 60/466,612 29.04.03 US

Filing date 8 April 2004

Wipo publication date 11 November 2004

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096848 Priority application(s): WO2004/096848

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234350-Process for preparation of (+)-p-mentha-2,8-diene-1-ol

2004234345-Insulin analogs having protracted time action